1.
肝细胞癌中linc00261的相对表达水平与临床病理参数之间的关系
Correlation between linc00261 expression and clinicopathological characteristics of patients with hepatocellular carcinoma (n=74)
| Clinical parameter | Linc00261 | P | |
| High expression (n=37) | Low expression (n=37) | ||
| a: Portal vein tumor thrombosis; b: Micro-vascular invasion. | |||
| Gender | 0.207 | ||
| Male | 33 | 29 | |
| Female | 4 | 8 | |
| Age (year) | |||
| ＜60 | 30 | 30 | 1.000 |
| ≥60 | 7 | 7 | |
| AFP (μg/L) | 0.032 | ||
| ＜400 | 27 | 18 | |
| ≥400 | 10 | 19 | |
| Cirrhosis | 0.772 | ||
| Positive | 29 | 30 | |
| Negative | 8 | 7 | |
| Tumor number | 1.000 | ||
| =1 | 30 | 30 | |
| ＞1 | 7 | 7 | |
| Tumor size (cm) | 0.007 | ||
| ≤3 | 14 | 4 | |
| ＞3 | 23 | 33 | |
| Tumor capsule | 0.619 | ||
| Positive | 24 | 26 | |
| Negative | 13 | 11 | |
| Differentiation | 0.295 | ||
| Well | 7 | 5 | |
| Modrate | 26 | 23 | |
| Poor | 4 | 9 | |
| MVIa | 0.010 | ||
| Positive | 14 | 25 | |
| Negative | 23 | 12 | |
| PVTTb | 0.102 | ||
| Positive | 3 | 8 | |
| Negative | 34 | 29 | |
| TNM stage | 0.020 | ||
| Ⅰ+Ⅱ | 31 | 22 | |
| Ⅲ+Ⅳ | 6 | 15 | |
| BCLC stage | 0.155 | ||
| A | 26 | 18 | |
| B | 3 | 4 | |
| C | 8 | 15 | |